Jamey Young
-
Fall faculty assembly reveals ‘Grow with Vanderbilt’ as guiding theme for academic year
Vanderbilt faculty filled the Student Life Center for the 2025 Fall Faculty Assembly on Aug. 28, listening as Chancellor Daniel Diermeier and Provost C. Cybele Raver lauded their achievements and dedication to students. Faculty Senate Chair Tyler Barrett opened this year’s assembly, encouraging the room to “Grow with Vanderbilt,” the faculty theme for the 2025–26 academic year. Read MoreSep 3, 2025
-
NIH training program in engineering and diabetes competitively renewed for another five years
The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has renewed a five-year grant through the NIH’s flagship T32 institutional training grant program. T32 grants provide funding to support students and postdoctoral trainees working in focused areas of research that advance the NIH mission. Read MoreJul 29, 2024
-
Vanderbilt scientists develop an algae time machine, advancing biomedicine
A Vanderbilt scientific team has succeeded in adjusting the daily biological clock of cyanobacteria, making the blue-green algae a more prolific producer of renewable fuels, chemicals, and pharmaceuticals, like insulin. Read MoreMay 14, 2024
-
A $3M NSF grant to advance biomanufacturing could help establish an innovative method to deliver medicines to cells
“Biomanufacturing is a growing but critical field that is reshaping how we diagnose and treat some of the most devastating diseases known to humanity,” said Jamey Young, Cornelius Vanderbilt Professor of Chemical and Biomolecular Engineering and principal investigator on the four-year grant. “Vanderbilt is uniquely well-suited to help advance the future of biomanufacturing, given our... Read MoreSep 29, 2023
-
Wikswo, VIIBRE team on track to build third-generation ‘self-driving lab’ with $1M from NSF
John Wikswo, founder and director of the Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, is the principal investigator of a $1 million award from the National Science Foundation. The object is to build a pathbreaking “robot scientist”—a fully automated microfluidic system for parallel, independent, long-duration, machine-guided experiments. The... Read MoreMar 5, 2022
-
Wikswo, VIIBRE team on track to build third-generation ‘self-driving lab’ with $1M from NSF
John Wikswo, founder and director of the Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, is the principal investigator of a $1 million award from the National Science Foundation. The object is to build a pathbreaking “robot scientist”—a fully automated microfluidic system for parallel, independent, long-duration, machine-guided experiments. The... Read MoreMar 5, 2022
-
New Extracellular Vesicle Research Center launches; NSF grant is an early success
On July 1, the Program for Extracellular Vesicle Research became one of the nine official centers and institutes associated with the School of Medicine Basic Sciences. The Center for Extracellular Vesicle Research is led by Professor of Cell and Developmental Biology Alissa Weaver, who holds the Cornelius Vanderbilt Chair and also led the center’s previous incarnation as a program.... Read MoreJul 12, 2021
-
New Extracellular Vesicle Research Center launches; NSF grant is an early success
On July 1, the Program for Extracellular Vesicle Research became one of the nine official centers and institutes associated with the School of Medicine Basic Sciences. The Center for Extracellular Vesicle Research is led by Professor of Cell and Developmental Biology Alissa Weaver, who holds the Cornelius Vanderbilt Chair and also led the center’s previous incarnation as a program.... Read MoreJul 12, 2021
-
Widely used software, developed by Young Lab, tops 1,000 academic licenses
INCA enables robust metabolic tracer studies A software tool for metabolic analysis developed by a Vanderbilt chemical engineer recently passed 1,000 total academic licenses and is the most licensed software on the university’s online licensing and e-commerce platform. Additionally, it was the third highest revenue generator on the platform, VU e-Innovations, for 2020. About 20... Read MoreApr 15, 2021
-
Widely used software, developed by Young Lab, tops 1,000 academic licenses
INCA enables robust metabolic tracer studies A software tool for metabolic analysis developed by a Vanderbilt chemical engineer recently passed 1,000 total academic licenses and is the most licensed software on the university’s online licensing and e-commerce platform. Additionally, it was the third highest revenue generator on the platform, VU e-Innovations, for 2020. About 20... Read MoreApr 15, 2021
-
NSF seed grant supports biomanufacturing of new drug delivery technologies
Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no side effects. The ability to engineer the... Read MoreOct 2, 2020
-
Melanoma study finds new way to enhance targeted therapies
With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. Read MoreMar 9, 2017
-
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read MoreJan 12, 2017
-
Vanderbilt researcher’s look at fatty liver disease hits home with dad’s diagnosis
Jamey Young, assistant professor of chemical and biomolecular engineering, wants to learn more about the estimated 5-10 percent of people with nonalcoholic fatty liver disease who never develop its deadliest complications in the hopes of developing new treatments. Read MoreJun 11, 2015
-
Beta cell link to fasting glucose
New findings explain why variation in a particular gene is the most important determinant of fasting blood glucose levels in humans. Read MoreJan 22, 2015
-
It’s his metabolism: Research into cell processes could lead to breakthroughs for diabetes and cancer
Jamey Young, assistant professor of chemical and biomolecular engineering, likes to build bridges. But rather than physical structures, Young focuses on spanning the divide between biology and engineering, diabetes and cancer, and plants and animals. Read MoreJul 2, 2012